Mycobacterium Avium Complex
What's New
Last Posted: May 24, 2024
- Phenotypic amikacin resistance may not indicate poor response to amikacin in Mycobacterium avium complex pulmonary disease.
L M Minuk, et al. Antimicrobial agents and chemotherapy 2024 0 e0008424 - Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype.
Koh Won-Jung, et al. The European respiratory journal 2017 0 (3) - Sputum Detection of Predisposing Genetic Mutations in Women with Pulmonary Nontuberculous Mycobacterial Disease.
Philley Julie V, et al. Scientific reports 2018 0 (1) 11336 - Prevalence and importance of non-tuberculous mycobacteria in adult patients with cystic fibrosis in a hospital in Madrid.
Fernández-Caso Belén, et al. Enfermedades infecciosas y microbiologia clinica (English ed.) 2019 0 (7) 323-326 - NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1? response and host susceptibility.
Wu Ming-Fang, et al. Scientific reports 2019 0 (1) 12534 - Sex-specific associations between susceptibility to Mycobacterium avium complex-lung disease and PDCD-1 gene polymorphisms.
Pan Sheng Wei, et al. The Journal of infectious diseases 2022 0 - Genome-wide association study in patients with pulmonary Mycobacterium avium complex disease.
Namkoong Ho, et al. The European respiratory journal 2021 2 - Association of SLC11A1 (NRAMP1) polymorphisms with pulmonary Mycobacterium avium complex infection.
Sapkota Bishwa Raj, et al. Human immunology 2012 5 (5) 529-36 - Disseminated infection with mycobacterium avium complex
From NCATS Genetic and Rare Diseases Information Center - Mycobacterium Avium Complex
From NCATS Genetic and Rare Diseases Information Center
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: